Foot-and-Mouth Disease Virus Capsid Protein VP1 Antagonizes Type I Interferon Signaling via Degradation of Histone Deacetylase 5

Foot-and-mouth disease (FMD) is a highly contagious and economically important disease of cloven-hoofed animals that hampers trade and production. To ensure effective infection, the foot-and-mouth disease virus (FMDV) evades host antiviral pathways in different ways. Although the effect of histone deacetylase 5 (HDAC5) on the innate immune response has previously been documented, the precise molecular mechanism underlying HDAC5-mediated FMDV infection is not yet clearly understood. In this study, we found that silencing or knockout of HDAC5 promoted FMDV replication, whereas HDAC5 overexpression significantly inhibited FMDV propagation. IFN-β and IFN-stimulated response element (ISRE) activity was strongly activated through the overexpression of HDAC5. The silencing and knockout of HDAC5 led to an increase in viral replication, which was evident by decreased IFN-β, ISG15, and ISG56 production, as well as a noticeable reduction in IRF3 phosphorylation. Moreover, the results showed that the FMDV capsid protein VP1 targets HDAC5 and facilitates its degradation via the proteasomal pathway. In conclusion, this study highlights that HDAC5 acts as a positive modulator of IFN-β production during viral infection, while FMDV capsid protein VP1 antagonizes the HDAC5-mediated antiviral immune response by degrading HDAC5 to facilitate viral replication.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:13

Enthalten in:

Cells - 13(2024), 6 vom: 19. März

Sprache:

Englisch

Beteiligte Personen:

Gong, Qing [VerfasserIn]
Ren, Shanhui [VerfasserIn]
Dou, Yongxi [VerfasserIn]
Tadele, Berihun Afera [VerfasserIn]
Hu, Tao [VerfasserIn]
Zhou, Luoyi [VerfasserIn]
Wang, Tao [VerfasserIn]
Yao, Kaishen [VerfasserIn]
Xu, Jian [VerfasserIn]
Yin, Xiangping [VerfasserIn]
Sun, Yuefeng [VerfasserIn]

Links:

Volltext

Themen:

Capsid Proteins
FMDV infection
HDAC5
IFN-β
Innate immune response
Interferon Type I
Journal Article
VP1

Anmerkungen:

Date Completed 28.03.2024

Date Revised 17.04.2024

published: Electronic

Citation Status MEDLINE

doi:

10.3390/cells13060539

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM37023930X